Trial record 1 of 1 for:    NCT01286987
Previous Study | Return to List | Next Study

Study of BMN 673, a PARP Inhibitor, in Patients With Advanced or Recurrent Solid Tumors

This study is currently recruiting participants.
Verified March 2014 by BioMarin Pharmaceutical
Sponsor:
Information provided by (Responsible Party):
BioMarin Pharmaceutical
ClinicalTrials.gov Identifier:
NCT01286987
First received: January 26, 2011
Last updated: March 25, 2014
Last verified: March 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: No date given
  Estimated Primary Completion Date: December 2014 (Final data collection date for primary outcome measure)